While Cg Oncology Inc has underperformed by -2.48%, investors are advised to look at stock chart patterns for technical insight.
On January 07, 2025, TD Cowen started tracking Cg Oncology Inc (NASDAQ: CGON) recommending Buy. A report published by UBS on October 24, 2024, Initiated its previous ‘Buy’ rating for CGON. RBC Capital Mkts also rated CGON shares as ‘Outperform’, setting a target price of $66 on the company’s shares in an initiating report dated September 23, 2024. ROTH MKM Initiated an Buy rating on August 28, 2024, and assigned a price target of $65. BofA Securities initiated its ‘Buy’ rating for CGON, as published in its report on June 28, 2024. Morgan Stanley’s report from February 20, 2024 suggests a price prediction of $55 for CGON shares, giving the stock a ‘Overweight’ rating. Goldman also rated the stock as ‘Neutral’.
Analysis of Cg Oncology Inc (CGON)
In order to gain a clear picture of Cg Oncology Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. Taking into account the quick ratio of the company, currently set at 35.32, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 648.18K can be a very valuable indicator of volatility for CGON stock. On a monthly basis, the volatility of the stock is set at 5.44%, whereas on a weekly basis, it is put at 4.84%, with a loss of -5.89% over the past seven days. Furthermore, long-term investors anticipate a median target price of $69.00, showing growth from the present price of $27.97, which can serve as yet another indication of whether CGON is worth investing in or should be passed over.
How Do You Analyze Cg Oncology Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 37.74%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 61.82% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CGON shares are owned by institutional investors to the tune of 61.82% at present.
